- Home
- INM vs LIPO Comparison
INM vs LIPO Comparison
Compare INM & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- LIPO
- Stock Information
- Founded
- INM 1981
- LIPO 2005
- Country
- INM Canada
- LIPO United States
- Employees
- INM N/A
- LIPO N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- LIPO Health Care
- Exchange
- INM Nasdaq
- LIPO Nasdaq
- Market Cap
- INM 3.2M
- LIPO 3.1M
- IPO Year
- INM N/A
- LIPO 2022
- Fundamental
- Price
- INM $2.87
- LIPO $2.99
- Analyst Decision
- INM
- LIPO
- Analyst Count
- INM 0
- LIPO 0
- Target Price
- INM N/A
- LIPO N/A
- AVG Volume (30 Days)
- INM 4.1M
- LIPO 39.2K
- Earning Date
- INM 05-12-2025
- LIPO 05-14-2025
- Dividend Yield
- INM N/A
- LIPO N/A
- EPS Growth
- INM N/A
- LIPO N/A
- EPS
- INM N/A
- LIPO N/A
- Revenue
- INM $4,920,990.00
- LIPO $519,866.00
- Revenue This Year
- INM N/A
- LIPO N/A
- Revenue Next Year
- INM N/A
- LIPO N/A
- P/E Ratio
- INM N/A
- LIPO N/A
- Revenue Growth
- INM N/A
- LIPO 8.88
- 52 Week Low
- INM $1.72
- LIPO $1.97
- 52 Week High
- INM $15.70
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- INM 50.24
- LIPO 58.50
- Support Level
- INM $2.74
- LIPO $2.75
- Resistance Level
- INM $3.45
- LIPO $3.17
- Average True Range (ATR)
- INM 0.70
- LIPO 0.29
- MACD
- INM 0.03
- LIPO 0.02
- Stochastic Oscillator
- INM 9.40
- LIPO 81.05
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.